Filing Details
- Accession Number:
- 0001415889-25-013642
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-19 16:30:34
- Reporting Period:
- 2025-05-16
- Filing Date:
- 2025-05-19
- Accepted Time:
- 2025-05-19 16:30:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1211583 | Fennec Pharmaceuticals Inc. | FENC | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1468316 | Rosty Raykov | C/O Fennec Pharmaceuticals, Inc. Po Box 13628, 68 Tw Alexander Drive Research Triangle Park NC 27709 | No | No | No | No |
Transaction Summary
| Sold: | 16,667 shares | Avg. Price: $6.78 | Total Value: $113,002.26 |
| Number of Shares After Transactions: | 70,254 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2025-05-16 | 33,334 | $0.00 | 86,921 | No | 4 | A | Direct | |
| Common Shares | Disposition | 2025-05-16 | 16,667 | $6.78 | 70,254 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares released from restriction from shares awarded 5-16-2024.
- The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain restricted stock units.
Billionaire Hedge Funds
